Kelly Lawrence W & Associates Inc Regeneron Pharmaceuticals, Inc. Transaction History

Kelly Lawrence W & Associates Inc

$430 Million
Q3 2024

A detailed history of Kelly Lawrence W & Associates Inc transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Kelly Lawrence W & Associates Inc holds 238 shares of REGN stock, worth $169,551. This represents 0.06% of its overall portfolio holdings.

Number of Shares

238

Previous 238 -0.0%

Holding current value

$169,551

Previous $250,000 -0.0%

% of portfolio

0.06%

Previous 0.06%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$883.2 - $1071.19 $3,532 - $4,284	4 Added 1.71%	238 $250,000
Q1 2024 May 15, 2024	SELL	$902.69 - $993.35 $5,416 - $5,960	-6 Reduced 2.5%	234 $225,000
Q3 2023 Nov 14, 2023	SELL	$692.45 - $844.37 $86,556 - $105,546	-125 Reduced 34.25%	240 $197,000
Q2 2023 Aug 14, 2023	SELL	$700.03 - $830.35 $14,000 - $16,607	-20 Reduced 5.19%	365 $262,000
Q1 2021 May 17, 2021	BUY	$446.73 - $548.2 $15,188 - $18,638	34 Added 9.69%	385 $182,000
Q4 2020 Feb 12, 2021	SELL	$478.3 - $607.98 $404,163 - $513,743	-845 Reduced 70.65%	351 $170,000
Q3 2020 Nov 13, 2020	BUY	$544.75 - $658.21 $10,895 - $13,164	20 Added 1.7%	1,196 $669,000
Q2 2020 Aug 14, 2020	SELL	$493.32 - $643.92 $160,329 - $209,274	-325 Reduced 21.65%	1,176 $733,000
Q1 2020 May 14, 2020	SELL	$336.18 - $494.43 $991,731 - $1.46 Million	-2,950 Reduced 66.28%	1,501 $733,000
Q3 2019 Nov 14, 2019	BUY	$273.46 - $318.39 $91,609 - $106,660	335 Added 8.14%	4,451 $1.24 Million
Q2 2019 Aug 14, 2019	SELL	$299.6 - $414.82 $55,426 - $76,741	-185 Reduced 4.3%	4,116 $1.29 Million
Q1 2019 May 15, 2019	SELL	$372.08 - $439.57 $524,632 - $619,793	-1,410 Reduced 24.69%	4,301 $1.77 Million
Q4 2018 Feb 14, 2019	SELL	$335.82 - $403.04 $6.7 Million - $8.04 Million	-19,949 Reduced 77.74%	5,711 $2.13 Million
Q3 2018 Nov 14, 2018	BUY	$351.14 - $408.51 $152,745 - $177,701	435 Added 1.72%	25,660 $10.4 Million
Q2 2018 Aug 14, 2018	BUY	$284.6 - $344.99 $85,380 - $103,497	300 Added 1.2%	25,225 $8.7 Million
Q1 2018 May 15, 2018	SELL	$315.82 - $393.78 $107,378 - $133,885	-340 Reduced 1.35%	24,925 $8.58 Million
Q3 2017 Nov 15, 2017	BUY	$431.38 - $504.0 $10.9 Million - $12.7 Million	25,265	25,265 $11.3 Million

Others Institutions Holding REGN

# of Institutions

1,534

Shares Held

83.6M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $76.4B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kelly Lawrence W & Associates Inc, based on Form 13F filings with the SEC.

News

Stay updated on Kelly Lawrence W & Associates Inc with notifications on news.

Account

Kelly Lawrence W & Associates Inc Regeneron Pharmaceuticals, Inc. Transaction History